Page last updated: 2024-08-23

colforsin and sr 144528

colforsin has been researched along with sr 144528 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's7 (70.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brockie, HC; Makriyannis, A; Murphy, VL; Pertwee, RG; Ross, RA; Stevenson, LA; Templeton, F1
Bouaboula, M; Casellas, P; Dornand, J; Gross, A; Liautard, JP; Marchant, J; Ouahrani-Bettache, S; Terraza, A1
Brockie, HC; Pertwee, RG; Ross, RA1
Bifulco, M; Bisogno, T; De Petrocellis, L; Di Marzo, V; Melck, D; Orlando, P; Vogel, Z; Zagoory, O1
Dubinett, SM; Gardner, B; Liu, Q; Makriyannis, A; Sharma, S; Tashkin, DP; Zu, LX1
Adra, CN; Shimoda, LM; Small-Howard, AL; Turner, H1
Bingham, B; Chlenov, M; Cummons, TA; Harrison, JE; He, Y; Jones, PG; Kennedy, JD; Kotnis, S; Lu, P; Piesla, MJ; Resnick, L; Smith, VA; Strassle, BW; Sun, SC; Uveges, AJ; Whiteside, GT1
Dekkers, BG; Dröge, MJ; Elzinga, CR; Gkoumassi, E; Meurs, H; Nelemans, SA; Schmidt, M; Zaagsma, J1
Gertsch, J; Lazo, JS; Schreiter, B; Wang, L; Xie, XQ; Xie, Z; Zhang, Y1
Ahmad, S; Groblewski, T; Ndong, C; O'Donnell, D1

Other Studies

10 other study(ies) available for colforsin and sr 144528

ArticleYear
Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    British journal of pharmacology, 1999, Volume: 126, Issue:3

    Topics: Animals; Benzoxazines; Binding, Competitive; Camphanes; Cannabinoids; CHO Cells; Chromans; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Tritium

1999
A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis.
    Journal of leukocyte biology, 2000, Volume: 67, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Antigens, CD; Benzoxazines; Brucella; Calcitriol; Camphanes; Cell Differentiation; Cell Line; Colforsin; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Intercellular Adhesion Molecule-1; Macrophage Activation; Macrophages; Mice; Monocytes; Morpholines; Naphthalenes; Phagocytosis; Piperidines; Pyrazoles; Reactive Oxygen Species; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

2000
Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.
    European journal of pharmacology, 2000, Aug-04, Volume: 401, Issue:2

    Topics: Amides; Animals; Benzoxazines; Camphanes; Cannabinoids; Cell Line; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Humans; Lipopolysaccharides; Macrophages; Morpholines; Naphthalenes; Nitric Oxide; Palmitic Acids; Pertussis Toxin; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Stereoisomerism; Time Factors; Virulence Factors, Bordetella

2000
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    The Biochemical journal, 2001, Aug-15, Volume: 358, Issue:Pt 1

    Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arachidonic Acids; Blotting, Western; Breast Neoplasms; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Capsaicin; Cell Division; Colforsin; COS Cells; Cyclic AMP; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Glycerides; Humans; Hydrolysis; Inhibitory Concentration 50; Palmitic Acids; Polyunsaturated Alkamides; Protein Binding; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured

2001
Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta.
    Biochemical and biophysical research communications, 2002, Jan-11, Volume: 290, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Autocrine Communication; Blotting, Northern; Blotting, Western; Camphanes; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Down-Regulation; Dronabinol; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; GTP-Binding Proteins; Humans; Immunoenzyme Techniques; Lymphocytes; Models, Biological; Paracrine Communication; Piperidines; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; RNA; Transforming Growth Factor beta; Up-Regulation; Virulence Factors, Bordetella

2002
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
    The Biochemical journal, 2005, Jun-01, Volume: 388, Issue:Pt 2

    Topics: Adenylyl Cyclases; Animals; Arachidonic Acids; Camphanes; Cell Line; Colforsin; Cyclic AMP; Cytosol; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Indoles; Ligands; Mast Cells; Morpholines; Pertussis Toxin; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Time Factors; Transcription, Genetic; Up-Regulation

2005
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.
    British journal of pharmacology, 2007, Volume: 151, Issue:7

    Topics: Analgesics; Animals; Benzoxazines; Calcium Channel Blockers; Camphanes; Cannabinoids; Carrageenan; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Hyperalgesia; Indoles; Mice; Morpholines; Naphthalenes; Protein Binding; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB2; Species Specificity; Stereoisomerism; Tritium

2007
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    British journal of pharmacology, 2007, Volume: 151, Issue:7

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Analgesics; Arachidonic Acids; Blotting, Western; Bronchi; Camphanes; Cannabinoids; Cell Line; Colforsin; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Drug Antagonism; Epithelial Cells; Humans; Immunosuppressive Agents; Interleukin-8; Pertussis Toxin; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Tumor Necrosis Factor-alpha

2007
Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor.
    International immunopharmacology, 2011, Volume: 11, Issue:9

    Topics: Adenylyl Cyclases; Amino Acid Substitution; Benzoxazines; Binding Sites; Binding, Competitive; Camphanes; Cell Line, Transformed; Cell Membrane; Colforsin; Computer Simulation; Cyclic AMP; Cyclohexanols; HEK293 Cells; Humans; Ligands; Models, Molecular; Morpholines; Mutagenesis, Site-Directed; Naphthalenes; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB2; Receptors, G-Protein-Coupled; Recombinant Proteins; Signal Transduction

2011
Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.
    European journal of pharmacology, 2011, Nov-01, Volume: 669, Issue:1-3

    Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Base Sequence; Benzoxazines; Binding, Competitive; Camphanes; CHO Cells; Cloning, Molecular; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Dogs; Dronabinol; Endocannabinoids; Humans; Mice; Molecular Sequence Data; Morpholines; Naphthalenes; Pan troglodytes; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB2; Sequence Alignment

2011